|1||Active, not recruiting||
SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)
|2||Not yet recruiting||
Tissue Repository: CTCL Collection Protocol
Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma
† Study has passed its completion date and status has not been verified in more than two years.